Julkaisut

Uusimmat julkaisut sisältää professori Mikael Knipin julkaisut. Valikoidut julkaisut sisältää PEDIA-ryhmän tärkeimpiä julkaisuja  vuodesta 2014 lähtien. Väitöksissä on PEDIA-ryhmässä tehtyjä väitöskirjoja, joissa on ollut ohjaajana Professori Mikael Knipin ja/tai Professori Outi Vaarala.

Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial. JAMA 2018; 319: 38-48.

Avoidance of Cow's Milk-Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial. Gastroenterology 2017; 153: 961-970.

Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia 2017; 60: 424-431.

Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. Proc Natl Acad Sci U S A 2017; 114: E6166-E6175.

Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility. Diabetologia 2017; 60: 1284-1293.

Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity. Diabetologia 2017; 60: 1223-1233.

Circulating CXCR5+PD-1+ICOS+ Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies. Diabetes 2017: 66: 437-447.

Natural history of the infant gut microbiome and impact of antibiotic treatments on strain-level diversity and stability. Sci Transl Med 2016; 8: 343ra81.

Increased circulating concentrations of mesencephalic astrocyte-derived neurotrophic factor in children with type 1 diabetes. Sci Rep 2016;6: 29058.

Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell 2016; 165: 1551.

The role of the intestinal microbiota in type 1 diabetes mellitus. Nature Rev Endocrinol 2016; 12: 154-167.

ConStrains identifies microbial strains in metagenomic datasets. Nat Biotechnol 2015; 33: 1045-1052.

Oral glucose tolerance test and random plasma glucose in prediction of type 1 diabetes. Diabetologia 2015; 58: 1787-1796.

Serum Proteomes Distinguish Children Developing Type 1 Diabetes in a Cohort With HLA-Conferred Susceptibility. Diabetes 2015; 64: 2265-2278. 

HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk. Diabetes 2015; 64: 1719-1727.

The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host & Microbe 2015; 17: 260-273.

Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans. J Immunol 2015 Jan 1; 194:68-75.

Microbial exposures in infancy and subsequent appearance of type 1 diabetes-associated autoantibodies: a cohort study. JAMA Pediatrics 2014; 168: 755-763.

Hydrolyzed Infant Formula and Early β-Cell Autoimmunity - A Randomized Clinical Trial. JAMA 2014; 311: 2279-2287.

Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes 2014; 63: 2402-2414.

Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes. Diabetes 2014; 63: 446-455.